CIS
NVO

Continental Investors Services’s Novo Nordisk NVO Stock Holding History

Continental Investors Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,203
Closed -$260K – 67
2024
Q3 		$260K Sell
2,203
-40
-2% -$5.33K 0.53% 52
2024
Q2 		$320K Buy
2,243
+79
+4% +$10.5K 0.71% 41
2024
Q1 		$276K Buy
2,164
+103
+5% +$12.3K 0.65% 46
2023
Q4 		$213K Buy
+2,061
New +$204K 0.55% 52
2023
Q3 		– Sell
-2,988
Closed -$241K – 55
2023
Q2 		$241K Buy
+2,988
New +$244K 0.29% 60

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Continental Investors Services's NVO Position: Q4 2024 in Review

Continental Investors Services sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,203 shares — an estimated $260K sold.

Continental Investors Services first reported a position in NVO in Q2 2023 and held it in 5 quarters. The position peaked at $320K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Continental Investors Services reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Continental Investors Services sold 2,203 Novo Nordisk shares in Q4 2024, an estimated $260K.
  • Continental Investors Services first reported a position in Novo Nordisk in Q2 2023 and held it in 5 quarters.
  • Continental Investors Services's Novo Nordisk position peaked at $320K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Continental Investors Services's 13F filing for Q4 2024, filed 11 Feb 2025.